相关实验视频

Updated: Jul 9, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

富可丁对CCl₄诱导的肝纤维化产生剂量依赖的抗纤维和抗炎作用

Vasilii N Slautin^1,2, Dmitry Yu Grebnev^3,4, Irina Yu Maklakova^3,4

¹Federal State Budgetary Institution of Higher Professional Education, Ural State Medical University", 3, Repin Street, 620028, Yekaterinburg, Russian Federation. slautinvasilij@gmail.com.

Journal of natural medicines

|June 30, 2023

概括

富可丁是一种海洋化合物,有效降低小鼠肝纤维化和炎症. 这项研究证实了其剂量依赖的抗纤维素作用,通过抑制关键的炎症标志物和减少肝损伤.

科学领域:

肝病学肝病学是一种肝病学.
海洋天然产品海洋天然产品
药理学药理学是指药理学的学科.

背景情况:

肝纤维化缺乏有效的非手术治疗方法.
富可丁显示出潜在的肝保护性,抗炎性和抗氧化性质.
调查富可桑对肝纤维化的治疗潜力至关重要.

研究的目的:

为了研究富可桑丁的抗纤维和抗炎作用.
为了阐明福可桑丁在肝纤维化中的作用的潜在机制.
在碳四化物诱导的小鼠模型中评估富可桑丁的疗效.

主要方法:

在ICR/CD1小鼠中,碳四化物 (CCl4) 诱导的肝纤维化模型.
组织病理学分析 (H&E,Sirius Red) 和免疫组织化学分析 (CD45,α-SMA,TIMP-1,MMP-9).
对肝酶 (ALT,AST),白蛋白,胆红素和炎症性细胞因子 (IL-1β,TNF-α) 的生物化学测试.

主要成果:

富可丁显著降低了肝纤维化严重程度和益菌原性标志物.
富可丁降低了炎症细胞透和促炎细胞因子 (IL-1β,TNF-α).
观察到富可丁的剂量依赖的抗纤维素作用.

结论:

富可丁在肝纤维化的小鼠模型中显示出显著的抗纤维作用.
抗炎作用与减少IL-1β和TNF-α合成有关.
富可丁代表了一种有前途的治疗药物,用于肝纤维化治疗.

关键词:

富可桑丁是一种富可桑丁 (fucoxanthin) 的成分.炎症炎症是一种炎症.肝脏纤维化肝脏纤维化在MMP-9中,它是MMP-9的.肌纤维细胞细胞.在TGF-β的基础上.

更多相关视频

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...